Rekvina Laboratories Limited Stock

Equities

VINRKLB

INE092O01028

Market Closed - Bombay S.E. Other stock markets 05:00:54 2021-12-13 EST			5-day change	1st Jan Change
4.5 ^INR	-.--%		-.--%	-.--%

06-11	Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary	CI
06-11	Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer	CI

Financials

Sales 2022	-	Sales 2023	-	Capitalization	27.13M 2.27B 37.14M
Net income 2022	- 0 0	Net income 2023	- 0 0	EV / Sales 2022	-
Net cash position 2022	3.68K 307K 5.04K	Net Debt 2023	716K 59.77M 980K	EV / Sales 2023	-
P/E ratio 2022	-34.6 x	P/E ratio 2023	-3,641 x	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Rekvina Laboratories Limited

Duration

Period

Style

Dynamic Chart

Latest news about Rekvina Laboratories Limited

Rekvina Laboratories Limited Announces Resignation of Surbhit Shah as Company Secretary	06-11	CI
Rekvina Laboratories Limited Appoints Srishty Bansal as Company Secretary and Compliance Officer	06-11	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-30	CI
Rekvina Laboratories Limited Appoints Pravin Chauhan as the Chief Financial Officer	05-22	CI
Rekvina Laboratories Limited Announces Management Changes	05-22	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-12	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Rekvina Laboratories Trims Net Loss in Fiscal Q4	23-06-08	MT
Rekvina Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-30	CI
Rekvina Laboratories Limited Appoints Bhavesh Prabhudas Vora as Non Executive, Additional Independent Director	22-11-14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-07	CI
Rekvina Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-11	CI
Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-06-23	CI

More news

Highs and lows

3 years

3.60

4.58

5 years

3.60

5.05

10 years

3.60

18.80

More quotes

Managers and Directors - Rekvina Laboratories Limited

Managers	Title	Age	Since
Mukeshbhai Jamnadas Shah CHM	Chairman	-	97-10-01
Akash Prajapati AUD	Comptroller/Controller/Auditor	-	23-05-02

Members of the board	Title	Age	Since
Mukeshbhai Jamnadas Shah CHM	Chairman	-	97-10-01
Amit Mukeshbhai Shah CEO	Chief Executive Officer	42	00-07-31
Bhavesh Prabhudas Vora BRD	Director/Board Member	57	22-11-13